KellBenx Inc. (noninvasive prenatal diagnostics for genetic disorders) has raised $2.4mm through its seed round. Of the four undisclosed backers, three were VC firms and the other was an angel investor. (Apr.)
KellBenx, which was formed in 2010, will use the proceeds to conduct a clinical trial and build a Long Island...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?